The French CANCERVIH network, coordinated by Prof. Jean-Philippe Spano of the Medical Oncology Department of the Pitié-Salpêtrière Hospital AP-HP and Sorbonne University, studied the efficacy and safety of immunotherapy on the world’s largest series of HIV-infected people with cancer treated in routine care (excluding clinical trials).
The results, which show that the treatment is effective and well tolerated, represent a real advance in the management of HIV-infected patients with cancer. They were published on 26 June 2019 in the journal AIDS.
Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience.
AIDS. 2019 Jun 26. doi: 10.1097/QAD.0000000000002298.